These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11721472)

  • 21. Interactions of carboplatin with fibrin(ogen), implications for local slow release chemotherapy.
    Gorodetsky R; Peylan-Ramu N; Reshef A; Gaberman E; Levdansky L; Marx G
    J Control Release; 2005 Jan; 102(1):235-45. PubMed ID: 15653148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect in vitro of lanthanum, yttrium and cerium chlorides on the 1st phase of the thrombin-fibrinogen reaction].
    Ducastaing A; Monceyron C; Azanza JL; Creac'h P; Raymond J
    C R Seances Soc Biol Fil; 1973; 167(2):262-9. PubMed ID: 4802769
    [No Abstract]   [Full Text] [Related]  

  • 23. Review of some unusual effects of calcium binding to fibrinogen.
    Mihalyi E
    Biophys Chem; 2004 Dec; 112(2-3):131-40. PubMed ID: 15572240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
    Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the esterase (TAMe) and clotting activities of human and bovine thrombin preparations.
    Lanchantin GF; Presant CA; Hart DW; Friedmann JA
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):159-75. PubMed ID: 16955973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sealing effect of fibrin glue against alveolar air leakage evaluated up to 48 h; comparison between different methods of application.
    Kawamura M; Gika M; Izumi Y; Horinouchi H; Shinya N; Mukai M; Kobayashi K
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):39-42. PubMed ID: 15923121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of L-asparaginase on fibrinogen and fibrin clot (current data on the tumor-inhibiting mechanism of L-asparaginase)].
    Benkö S; Laki K
    Orv Hetil; 1969 Sep; 110(36):2083-7. PubMed ID: 4900425
    [No Abstract]   [Full Text] [Related]  

  • 28. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
    Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
    Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The thrombin-fibrinogen interaction.
    Scheraga HA
    Biophys Chem; 2004 Dec; 112(2-3):117-30. PubMed ID: 15572239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Habu thrombin-like enzyme (THLE) with a new n-terminal sequence from the venom of Trimeresurus flavoviridis (Habu).
    Komori Y; Tanaka K; Nikai T
    J Nat Toxins; 2002 Aug; 11(3):205-12. PubMed ID: 12182540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunostimulatory action of L-4-oxalysine counteracts immunosuppression induced by alpha-fetoprotein.
    Wang XW; Xu B
    Eur J Pharmacol; 1998 Jun; 351(1):105-11. PubMed ID: 9698211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
    Sanchez J; Elgue G; Larsson R; Nilsson B; Olsson P
    Thromb Res; 2008; 122(2):257-63. PubMed ID: 18177925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of human thrombin for use in a fibrin glue.
    Rock G; Neurath D; Semple E; Harvey M; Freedman M
    Transfus Med; 2007 Jun; 17(3):187-91. PubMed ID: 17561860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The optimal technique for combined application of fibrin sealant and bioabsorbable felt against alveolar air leakage.
    Itano H
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):457-60. PubMed ID: 18243004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of thrombin and fibrinogen. The comparison of clotting time averages.
    Baughman DJ; Waugh DF; Juvkam-Wold C
    Thromb Diath Haemorrh; 1968 Dec; 20(3):477-96. PubMed ID: 5710466
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunopotentiating effects of oxalysine].
    Li XY; Tong LM; Jin YF; Cao CY; Liang HZ; Wang JF; Zhu PP; Wang JY
    Zhongguo Yao Li Xue Bao; 1987 Mar; 8(2):173-7. PubMed ID: 2959008
    [No Abstract]   [Full Text] [Related]  

  • 38. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suramin interaction with human alpha-thrombin: inhibitory effects and binding studies.
    Monteiro RQ; Campana PT; Melo PA; Bianconi ML
    Int J Biochem Cell Biol; 2004 Oct; 36(10):2077-85. PubMed ID: 15203120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the proteolytic activity of matrix metalloproteinase-2 (gelatinase A) on fibrinogen.
    Monaco S; Gioia M; Rodriguez J; Fasciglione GF; Di Pierro D; Lupidi G; Krippahl L; Marini S; Coletta M
    Biochem J; 2007 Mar; 402(3):503-13. PubMed ID: 17087661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.